Free Trial

Sage Therapeutics (SAGE) Insider Trading & Ownership

Sage Therapeutics logo
$4.91 0.00 (0.00%)
(As of 11/20/2024 ET)

Sage Therapeutics (NASDAQ:SAGE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.50%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$339,380.00
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$519,394.23
Get SAGE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sage Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SAGE Insider Buying and Selling by Quarter

Sage Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2023Elizabeth BarrettDirectorBuy2,000$18.64$37,280.00  
5/9/2023Elizabeth BarrettDirectorBuy1,000$50.50$50,500.00  
2/10/2023Jeffrey M JonasDirectorSell11,643$44.61$519,394.23  
5/5/2022George GolumbeskiDirectorBuy8,000$31.45$251,600.00  
(Data available from 1/1/2013 forward)

SAGE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Sage Therapeutics includes Elizabeth Barrett, George Golumbeski, and Jeffrey M Jonas. Learn more on insiders at SAGE.

5.50% of Sage Therapeutics stock is owned by insiders. Learn more on SAGE's insider holdings.

The following insider purchased SAGE shares in the last 24 months: Elizabeth Barrett ($87,780.00).

Insiders have purchased a total of 3,000 SAGE shares in the last 24 months for a total of $87,780.00 bought.

The following insider sold SAGE shares in the last 24 months: Jeffrey M Jonas ($519,394.23).

Insiders have sold a total of 11,643 Sage Therapeutics shares in the last 24 months for a total of $519,394.23 sold.

Sage Therapeutics Key Executives

  • Mr. Barry E. GreeneMr. Barry E. Greene (Age 61)
    President, CEO & Director
    Compensation: $1.29M
  • Ms. Kimi E. Iguchi CPA (Age 62)
    CFO & Treasurer
    Compensation: $665.37k
  • Ms. Anne Marie Cook Esq. (Age 62)
    Senior VP, General Counsel & Secretary
    Compensation: $711.6k
  • Mr. Christopher Benecchi (Age 52)
    Chief Business Officer
    Compensation: $703.76k
  • Dr. Laura Gault M.D.
    Ph.D., Chief Medical Officer
  • Mr. Matt Lasmanis
    Chief Technology & Innovation Officer
  • Mr. Mike Quirk
    Chief Scientific Officer
  • Ashley Kaplowitz
    Director of Investor Relations
  • Ms. Erin E. Lanciani (Age 55)
    Chief People & Experience Officer
  • Dr. Amy Schacterle Ph.D.
    Senior Vice President of R&D Strategy and Business Management


This page (NASDAQ:SAGE) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners